Article
Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression
2 Jun 2023
Abstract excerpt
Abstract Background Multiple sclerosis (MS) leads to demyelination and neurodegeneration with autoimmune responses in central nervous system. Patients begin with a relapsing–remitting (RR) course, and more than 80% of them may advance to secondary progressive MS (SPMS), which is characteristic for the gradual decline of neurological functions without demonstrated treating method to prevent. This study aims to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
